|
|
|
|
Vol. 14, Issue 8, 3459-3469, August 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Molecular Biology and Genetics, Cornell University, Ithaca, New
York 14853;
Biology Department, Ithaca College, Ithaca, New York 14850; and
|| GlaxoSmithKline Pharmaceuticals Research and Development, Harlow, Essex CM19
5AD, United Kingdom
Submitted November 5, 2002;
Revised February 11, 2003;
Accepted March 13, 2003
Monitoring Editor: Jennifer Lippincott-Schwartz
Recent studies have suggested that formation of Golgi membrane tubules
involves the generation of membrane-associated lysophospholipids by a
cytoplasmic Ca2+-independent phospholipase A2
(PLA2). Herein, we provide additional support for this idea by
showing that inhibition of lysophospholipid reacylation by a novel
Golgi-associated lysophosphatidylcholine acyltransferase (LPAT) induces the
rapid tubulation of Golgi membranes, leading in their retrograde movement to
the endoplasmic reticulum. Inhibition of the Golgi LPAT was achieved by
2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976), a previously
characterized antagonist of acyl-CoA cholesterol acyltransferase. The effect
of CI-976 was similar to that of brefeldin A, except that the coatomer subunit
-COP remained on Golgi-derived membrane tubules. CI-976 also enhanced
the cytosol-dependent formation of tubules from Golgi complexes in vitro and
increased the levels of lysophosphatidylcholine in Golgi membranes. Moreover,
preincubation of cells with PLA2 antagonists inhibited the ability
of CI-976 to induce tubules. These results suggest that Golgi membrane tubule
formation can result from increasing the content of lysophospholipids in
membranes, either by stimulation of a PLA2 or by inhibition of an
LPAT. These two opposing enzyme activities may help to coordinately regulate
Golgi membrane shape and tubule formation.
Present addresses: Laboratory of Intracellular Parasites, National
Institutes of Allergy and Infectious Diseases, Rocky Mountain Laboratory,
Hamilton, MT 59840; Perceptive Informatics, Inc., 900 Chelmsford St., Suite
308, Lowell, MA 01851.
¶ Corresponding author. E-mail address: wjb5{at}cornell.edu.
This article has been cited by other articles:
![]() |
S. K. Jackson, W. Abate, J. Parton, S. Jones, and J. L. Harwood Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response J. Leukoc. Biol., July 1, 2008; 84(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Kienesberger, A. Lass, K. Preiss-Landl, H. Wolinski, S. D. Kohlwein, R. Zimmermann, and R. Zechner Identification of an Insulin-regulated Lysophospholipase with Homology to Neuropathy Target Esterase J. Biol. Chem., February 29, 2008; 283(9): 5908 - 5917. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moreau, F. Brandizzi, S. Hanton, L. Chatre, S. Melser, C. Hawes, and B. Satiat-Jeunemaitre The plant ER-Golgi interface: a highly structured and dynamic membrane complex J. Exp. Bot., January 1, 2007; 58(1): 49 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Domanov and P. K. J. Kinnunen Antimicrobial Peptides Temporins B and L Induce Formation of Tubular Lipid Protrusions from Supported Phospholipid Bilayers Biophys. J., December 15, 2006; 91(12): 4427 - 4439. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Riekhof and D. R. Voelker Uptake and Utilization of Lyso-phosphatidylethanolamine by Saccharomyces cerevisiae J. Biol. Chem., December 1, 2006; 281(48): 36588 - 36596. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chambers, B. Judson, and W. J. Brown A unique lysophospholipid acyltransferase (LPAT) antagonist, CI-976, affects secretory and endocytic membrane trafficking pathways J. Cell Sci., July 15, 2005; 118(14): 3061 - 3071. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Lagace and N. D. Ridgway The Rate-limiting Enzyme in Phosphatidylcholine Synthesis Regulates Proliferation of the Nucleoplasmic Reticulum Mol. Biol. Cell, March 1, 2005; 16(3): 1120 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chan, M. Strang, B. Judson, and W. J. Brown Inhibition of Membrane Tubule Formation and Trafficking by Isotetrandrine, an Antagonist of G-protein-regulated Phospholipase A2 Enzymes Mol. Biol. Cell, April 1, 2004; 15(4): 1871 - 1880. [Abstract] [Full Text] [PDF] |
||||